The loan – disclosed by the World Bank in December – is being sought to fund construction of the plant in Kota Bukit Indah, Indonesia.
A spokesman for B.Braun told us “we can confirm that we sought a loan from the World Bank for our Indonesia production plant project.”
The facility – construction of which began in May – will make sterile parenteral drug preparations. The project is expected to be completed next June.
According to a plan posted on the World Bank’s website the plant will feature production areas, warehousing space, offices, a chiller and cooling tower, a flammable and toxic building, a high pressure boiler, a domestic and fire water tank, bus shelter and car park.
The bank said that manufacturing operations will focus on production and packaging of parenteral preparations adding that the products will “supply the Indonesian market but may also be exported.”
B. Braun generated revenue of €840m ($916m) from the Asia-Pacific region in 2014, primarily from the sale of products made at its manufacturing facilities in Europe and in China, India, Japan, Malaysia and Vietnam.
The German firm’s total revenue last year was €5.4bn.